Use of Cidofovir for Recurrent Respiratory Papillomatosis
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Recurrent respiratory papillomatosis (RRP) is the most common benign neoplasm of the larynx
in the pediatric population. The impact of the disease on patients and families can be
tremendous due to the need for frequent treatment. It would be highly beneficial to develop
effective medical therapies as adjunctive measures to surgical ablation with the goal of
reducing the frequency of reoccurrence.